MedicineToMarket.com is the definitive source for peer-generated insights
Experience the power of leveraging the knowledge and experience of your peers while enjoying curated content from around the web.
Understand the latest dynamics in customer engagement
Discover ways to turn data into actionable insights
Unlock fresh thinking to strengthen culture and diversify teams
Enhance trial efficiencies and deepen KOL relationships
Formulate winning approaches to deal making and negotiations
Go beyond omnichannel with patients, payers, and providers
Medicine to Market is an executive resource hub built by biotech leaders.
We believe we can accelerate healthcare innovation by providing unprecedented access to the people and ideas that can help eliminate the gap between sickness and solution.
In an ambitious move to tackle the soaring costs of prescription drugs, the Centers for Medicare and Medicaid Services (CMS) is...Read More
In a landmark agreement, Novo Nordisk and Eli Lilly have significantly reduced the prices of their obesity drugs, Wegovy and Zepbound,...Read More
Eisai, a leading pharmaceutical company, is preparing to submit a significant application to the U.S. Food and Drug Administration (FDA) next...Read More
In a significant move in healthcare policy, President Donald Trump has brokered a historic agreement that leads to substantial reductions in...Read More
Moderna, a prominent name in the biopharmaceutical landscape best known for its groundbreaking COVID-19 vaccine, is currently facing a substantial decline...Read More
In recent weeks, the landscape of the obesity treatment market has experienced significant upheaval, following Novo Nordisk’s proposal to acquire Metsera...Read More